Narrative review / 2017
Runners generally have a 25% to 40% reduced risk of premature mortality and live approximately 3 years longer than non-runners.
This review examines the impact of running on health outcomes, longevity, and premature mortality. It reports that runners generally experience a 25%-40% reduced risk of premature mortality and live approximately 3 years longer than non-runners. The review also evaluates whether longevity benefits diminish at higher doses of running and discusses underlying mechanisms linking running to chronic disease prevention.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Human populations (runners and non-runners)
- What was measured
- Premature mortality, life expectancy, and chronic disease prevention
THE PAPER
Running as a Key Lifestyle Medicine for Longevity.
Lee DC, Brellenthin AG, Thompson PD, Sui X, Lee IM, Lavie CJ. Prog Cardiovasc Dis, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.